Biophysical Characterization of α-Synuclein and Rotenone Interaction

Biophysical Characterization of α-Synuclein and Rotenone Interaction

Previous studies revealed that pesticides interact with α-synuclein and accelerate the rate of fibrillation. These results are consistent with the prevailing hypothesis that the direct interaction of α-synuclein with pesticides is one of many suspected factors leading to α-synuclein fibrillation and...

Full description

Bibliographic Details
Main Authors:	Anthony L. Fink, Ólöf Einarsdóttir, Blanca A. Silva, Vladimir N. Uversky
Format:	Article
Language:	English
Published:	MDPI AG 2013-09-01
Series:	Biomolecules
Subjects:	α-Synuclein Parkinson’s disease environmental toxin misfolding fibrillation intrinsically disordered protein pesticide agrochemical rotenone
Online Access:	http://www.mdpi.com/2218-273X/3/3/703

Similar Items

Hepcidin Decreases Rotenone-Induced α-Synuclein Accumulation via Autophagy in SH-SY5Y Cells
by: Meiqi Li, et al.
Published: (2020-10-01)

Ndfip1 Prevents Rotenone-Induced Neurotoxicity and Upregulation of α-Synuclein in SH-SY5Y Cells
by: Xin Liu, et al.
Published: (2021-01-01)

Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson’s disease in rats
by: Sanaa Ahmed, et al.
Published: (2022-06-01)

α-Synuclein Fibrils as Penrose Machines: A Chameleon in the Gear
by: Francesca De Giorgi, et al.
Published: (2022-03-01)

Decreasing α-synuclein aggregation by methanolic extract of Centella asiatica in zebrafish Parkinson's model
by: Husnul Khotimah, et al.
Published: (2015-11-01)

Rotenone: from modelling to implication in Parkinson’s disease
by: Khaled Radad, et al.
Published: (2019-11-01)

Alternative Structures of α-Synuclein
by: Dawid Dułak, et al.
Published: (2020-01-01)

Neural-Induced Human Adipose Tissue-Derived Stem Cells Conditioned Medium Ameliorates Rotenone-Induced Toxicity in SH-SY5Y Cells
by: Mahesh Ramalingam, et al.
Published: (2021-02-01)

The Impairments of α-Synuclein and Mechanistic Target of Rapamycin in Rotenone-Induced SH-SY5Y Cells and Mice Model of Parkinson’s Disease
by: Mahesh Ramalingam, et al.
Published: (2019-09-01)

Non-Reproducibility of Oral Rotenone as a Model for Parkinson’s Disease in Mice
by: Ellen Niederberger, et al.
Published: (2022-10-01)

Characterization of α-synuclein oligomers formed in the presence of lipid vesicles
by: Anvesh K.R. Dasari, et al.
Published: (2024-07-01)

Monitoring α-synuclein aggregation
by: Juan Estaun-Panzano, et al.
Published: (2023-01-01)

Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson’s Disease
by: Kensuke Ikenaka, et al.
Published: (2019-07-01)

α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise
by: Simona Daniele, et al.
Published: (2018-01-01)

Structural Specificity of Polymorphic Forms of α-Synuclein Amyloid
by: Irena Roterman, et al.
Published: (2023-04-01)

Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
by: Vandana Zaman, et al.
Published: (2022-11-01)

Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers
by: Ryan Limbocker, et al.
Published: (2021-06-01)

Initiation and propagation of α-synuclein aggregation in the nervous system
by: Baraa A. Hijaz, et al.
Published: (2020-03-01)

Rotenone aggravates PD-like pathology in A53T mutant human α-synuclein transgenic mice in an age-dependent manner
by: An-Di Chen, et al.
Published: (2022-08-01)

The α-Synuclein Monomer May Have Different Misfolding Mechanisms in the Induction of α-Synuclein Fibrils with Different Polymorphs
by: Nannan Zhao, et al.
Published: (2023-04-01)

Targeting α-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson’s disease
by: Gabriela Henriquez, et al.
Published: (2023-08-01)

Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology
by: Michael C. Pace, et al.
Published: (2018-05-01)

Assessment of Aggregated and Exosome-Associated α-Synuclein in Brain Tissue and Cerebrospinal Fluid Using Specific Immunoassays
by: Dimitrios Anagnostou, et al.
Published: (2023-06-01)

Cell Responses to Extracellular α-Synuclein
by: Alexei A. Surguchev, et al.
Published: (2019-01-01)

Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein
by: Hazel L. Roberts, et al.
Published: (2015-03-01)

Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity
by: Simona S. Ghanem, et al.
Published: (2021-06-01)

The effect of tyrosine residues on α-synuclein fibrillation
by: Katja Pirc, et al.
Published: (2015-01-01)

Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review
by: Abbie T. Rodger, et al.
Published: (2023-07-01)

Rational Generation of Monoclonal Antibodies Selective for Pathogenic Forms of Alpha-Synuclein
by: Ebrima Gibbs, et al.
Published: (2022-09-01)

The Effects of Vasointestinal Peptide and Naringenin on Rotenone-Induced Experimental Model of Parkinson's Disease
by: Recep Özmerdivenli, et al.
Published: (2023-08-01)

Effect of Electric Field on α-Synuclein Fibrils: Revealed by Molecular Dynamics Simulations
by: Jamoliddin Razzokov, et al.
Published: (2023-03-01)

Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease
by: Florian Bayersdorfer, et al.
Published: (2010-10-01)

Neuroprotective function of Omi to α-synuclein-induced neurotoxicity
by: Hea-Jong Chung, et al.
Published: (2020-03-01)

Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches
by: Marija Vidović, et al.
Published: (2022-05-01)

Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein
by: Seo-Jun Kang, et al.
Published: (2022-07-01)

Acetylated α-Tubulin and α-Synuclein: Physiological Interplay and Contribution to α-Synuclein Oligomerization
by: Alessandra Maria Calogero, et al.
Published: (2023-07-01)

β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP<sup>+</sup>) and 6-Hydroxydopamine (6-OHDA)
by: Marco Carli, et al.
Published: (2021-08-01)

Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
by: Darren J. Schofield, et al.
Published: (2019-12-01)

Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
by: Huang Yue, et al.
Published: (2012-01-01)

α-Synuclein Impacts on Intrinsic Neuronal Network Activity Through Reduced Levels of Cyclic AMP and Diminished Numbers of Active Presynaptic Terminals
by: Kristian Leite, et al.
Published: (2022-05-01)